Ertapenem Versus Piperacillin/Tazobactam in the Treatment of Complicated Intraabdominal Infections: Results of a Double-Blind, Randomized Comparative Phase III Trial

OBJECTIVE: To examine the clinical efficacy and safety of ertapenem, a novel β-lactam agent with wide activity against common pathogens encountered in intraabdominal infection. SUMMARY BACKGROUND DATA: Ertapenem has a pharmacokinetic profile and antimicrobial spectrum that support the potential for...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Solomkin, Joseph S., Yellin, Albert E., Rotstein, Ori D., Christou, Nicolas V., Dellinger, E. Patchen, Tellado, Jose M., Malafaia, Osvaldo, Fernandez, Alvaro, Choe, Kyuran A., Carides, Alexandra, Satishchandran, Vilas, Teppler, Hedy
Format: Artigo
Idioma:Inglês
Publicat: 2003
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1522141/
https://ncbi.nlm.nih.gov/pubmed/12560782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.SLA.0000048551.32606.73
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars